The genetics of melanoma is complex and, in addition to environmental influences, melanoma predisposition may involve many genes and gene interactions. Non-coding polymorphisms in the TYRP1 locus have been associated with skin and eyes pigmentation and with melanoma risk in Caucasian populations of north European ancestry. Recently, a functional SNP (rs683) located in the 3'UTR of the gene that alters the binding site of miR-155 and modifies the protein levels of the encoded enzyme has been identified. This polymorphism has not been evaluated as a susceptibility polymorphism for sporadic melanoma. Owing to determine if rs683 could be associated with melanoma risk, a genomic DNA fragment encompassing the variation was amplified, and the frequency of rs683 alleles in 250 sporadic melanoma patients and 303 control individuals was compared by Restriction Fragment Length Polymorphism (RFLP) analysis in an Italian population. No difference in the genotype distribution or allele frequency was observed indicating that this polymorphism has no important impact in melanoma risk in the Italian population analyzed.
Introduction
Cutaneous Malignant Melanoma (CMM) is the most aggressive skin cancer and the sixth most frequently diagnosed cancer in industrialized countries. The genetics of melanoma is complex and, in addition to environmental influences, melanoma predisposition may involve many genes and gene interactions (1) . Although a large number of association studies has been published (2) and novel risk factors have been identified, the molecular mechanisms behind melanoma development have not been entirely unraveled (3) . Identification of novel genes predisposing to melanoma will increase our understanding of the genetic pathogenesis of the disease and may contribute to the development of novel prevention and treatment of melanoma. Tyrosinase-related protein 1 (TYRP1) gene encodes a melanosomal enzyme that belongs to the tyrosinase family and plays an important role in melanin biosynthesis (4) . It is expressed in melanocytes and primarily localized in melanosomes and on the surface of melanocytes and melanoma cells (5) . TYRP1 is also a melanocyte differentiation antigen that is important for autoimmune destruction of melanocytes resulting in depigmentation or vitiligo (6) . It was also suggested that TYRP1 may be involved in the maintenance of melanosome structure and could affect melanocyte proliferation and cell death, as reviewed in Sara ngarajan et al. (7) . Functional mutations in this gene are associated with a moderate form of brown oculocutaneous albinism and oculocutaneous albinism type III (8, 9) . Candidate gene association studies have identified rs1408799 and rs2733832 in the TYRP1 gene region as risk polymorphisms for both inherited and sporadic cutaneous malignant melanoma (10, 11) . High TYRP1 expression in lymph node and skin metastases of melanoma patients significantly correlates with unfavorable clinical outcome (12, 13) but the same association was not observed between protein level and clinical outcome. In addition, a correlation was not observed between TYRP1 mRNA and protein level, and this discrepancy was demonstrated to occur due to post-transcriptional regulatory events that affect TYRP1 mRNA (14, 15) . MicroRNAs (miRNAs) are endogenous noncoding small RNA molecules that have recently emerged as fundamental post-transcriptional regulators of gene expression. miRNAs bind to the 3′ untranslated region (UTR) of target mRNAs and promote transcript degradation and/or negatively regulate the translational efficiency of their target mRNAs. Recent findings have revealed a significant role for miRNAs in melanoma (16, 17) . Polymorphisms on the 3'UTR region of genes can alter the binding capacity of a specific microRNA and can result in impaired post-transcriptional regulation of the mRNA (18) (19) (20) . TYRP1 3' UTR contains, among others, three putative miR-155 binding sites (http://www.microrna.org/microrna/home.do), two of which include a Single Nucleotide Polymorphism (rs683A/C and rs910A/C) in strong linkage disequilibrium (LD). These polymorphisms affect TYRP1 post-transcriptional regulation by miRNA-155 differential binding efficiency (15) . Alleles at these two SNPs are differentially distributed among human populations following their latitude of residence. The derived (mutant) allele of rs683 -and consequently the linked rs910-are nearly fixed in African populations (YRI) and East Asians (CHB+JPT), while in Europeans (CEU) both SNPs are highly polymorphic, with the derived alleles representing the minor form. It was suggested that the two SNPs located in miRNA-155 binding sites are direct targets of positive selection in YRI, CHB and JPT populations (14) . Extended analysis on additional 37 populations of rs683 allele frequencies performed by these Authors found that the closer to the Equator, the higher the frequency of the derived allele. The Authors suggest that miR-155 may act as a regulator to optimize TYRP1 expression for local adaptation to differential UV radiation along the latitudes. In the Caucasian population, the effects exerted by alleles at rs683 SNP may result in a reduced capacity of defense against UV damage and represent a risk factor for cutaneous melanoma. Owing to the positive association of non-coding SNPs in TYRP1 gene region with melanoma skin cancer, we sought to investigate if the association could be detected with the polymorphism rs683, located in a miR155 binding site, and which affects the post-transcriptional regulation of the gene. In this study we analyzed the allele frequency and genotype distribution of rs683A/C in an Italian population of sporadic melanoma and control individuals, and found no association of rs683 with melanoma risk.
Methods
Patients presenting sporadic cutaneous melanoma and control individuals were enrolled in the study. All subjects were Italian Caucasians. Familial or multiple melanoma cases and individuals with other neoplasias were excluded. Cases were patients hospitalized for surgical treatment of melanoma at the Melanoma and Sarcoma Surgery Unit of the "Istituto Nazionale Tumori", Milan, between May 2006 and June 2014. Controls were healthy donors from the S.T.O.P. study on early diagnosis of lung cancer, and from a gastroenterology study on FANS and gastric bleeding (Department of Diagnostic and Public Health, Pharmacology Unit, Verona University Hospital, Italy). The study was approved by the local Institutional Review Board, and informed consent was obtained from all subjects. The study group is described in Table 1 . Genomic DNA was extracted from whole blood using the QIAamp Blood Kit (Qiagen) or by standard saltingout method. A 336 base pair (bp) fragment encompassing the A to C polymorphic site in TYRP1 gene region was amplified using specific primers: 5′-TTCTAATACAAG-CATATGTTCG-3′ and 5′-AATCTGTTGACAAATATC-CA-3′. Amplification was performed in Eppendorf Mastercycler Ep Gradient S thermalcycler. Polymorphism rs683A>C was genotyped by RFLP analysis. Amplification products were digested for 4 hours at 65°C with 5 units of TaqI enzyme (Thermo Scientific). Digestion products were electrophoresed on 10% acrylamide gel.
Statistical Analysis
Genotypes were assessed and the Epi Info software package (version 2003) was used for assessing association using a 2 × 2 × n contingency table. χ2 tests, with Yates' correction or Fisher's exact test (two-tailed) were used for association. Odds ratios (ORs) and the OR 95% confidence interval were also calculated.
Results
A total of 250 melanoma patients and 303 control individuals were enrolled in the present study. Demographic characteristics and disease status of individuals are summarized in Table 1 . Controls were older than patients and in the control group slightly more men than women were present. Since rs683 locates in a natural restriction site for TaqI endonuclease, all individuals were genotyped by RFLP analysis. The minor allele frequency in the entire population was 0.41, in line with the frequency (0.42) for TSI (Toscani) population in the 1000 Genomes Database (http://www.1000genomes.org/home). The frequency of the rs683C allele was 0.39 and 0.42 in cases and controls, respectively, with no statistical significant difference between them (Pvalue= 0.3). No association was observed when testing the genotype distribution between cases and controls, including the recessive and dominant models, neither stratification by sex showed any specific association ( Table 2 ), indicating that rs683 is not associated with melanoma risk in the Italian population studied.
Discussion
Independent association studies have shown that two single nucleotide polymorphisms which are in strong linkage disequilibrium -rs1408799 located upstream of the TYRP1 gene, and rs2733832 located in intron 6-are associated with cutaneous melanoma and multiple primary melanoma in different Caucasian populations (10, 11, 21) . The identification of the causative polymorphisms responsible for the observed associations represents an important challenge, and suggestions of biological mechanisms in the regulation of melanogenesis, predicting the effects of regulatory polymorphisms or protein variation on function, or recognition of evolutionary conservation, are necessary. Several genome-wide expression studies have implicated a number of miRNAs and long non-coding RNA (lncRNAs) that are potentially important regulators of melanoma development, including miR-155 (22) (23) (24) . In the present study we evaluate for the first time the association of rs683, a functional polymorphism located in the 3'UTR of the TYRP1 gene, with mela noma risk. It has been demonstrated that TYRP1 mRNA is a target of miR-155, and that rs683 alters a binding site of this miR in the TYRP1 3'UTR, influencing the pro- Copyright © 2016 CIC Edizioni Internazionali Unauthorized reproduction of this article is prohibited.
tein level of the encoded enzyme (15) . Since rs683 SNP is contained in the same region as rs1408799 and rs2733832, it is possible to speculate that rs683 could be the polymorphism responsible for the association with melanoma risk observed in different studies (10, 11) . In the study by Gudbjartsson et al., the mayor part of melanoma patients analyzed were from Iceland, Sweden and north Eastern European countries (only 180 patients where from Spain), where pale skin with poor tanning response, red or blonde hair, blue or green eyes and freckles are frequent and represent the most important melanoma risk factors. Duffy et al. confirmed the association of the two noncoding SNPs (rs2733832 and rs1408799) with CMM in a highly sun-exposed Northern European ancestry population. Our results demonstrate no association of rs683 with melanoma risk in the Italian population; these results are in agreement with another study performed in a Spanish population (25) , where the frequency of the rs683 derived allele is similar to the Italian population (39%, 1000 Genome Database http://www.1000genomes.org/home). The Authors evaluated the association of one upstream and three intronic TYRP1 polymorphisms and found no association with melanoma risk. Together these results suggest that TYRP1 may not be directly associated with melanoma risk and may increase risk of CMM via its association with pigmentation characteristics, as suggested by Duffy et al. (10) .
In conclusion, results of the present study indicate that variants of rs683 of the TYRP1 gene are not associated or have a very low impact on melanoma risk in the analyzed Italian population.
